About LevitasBio
- Home
- /
- About Us
LevitasBio is unlocking a new dimension in cellular analysis.
Our mission is to advance science and human health by providing researchers with a new and powerful method of cellular analysis. While the last decade has seen tremendous advancement in analytical tools for genomics and proteomics such as next-generation sequencing, single cell genomics, and even phenotypic imaging down to single-cell resolution, there had been no innovation in the sample preparation and cellular analysis market for decades – until now.
Here at LevitasBio, we are delivering the first truly novel approach to cellular analysis in 30 years. Our proprietary label-free levitation technology enable researchers to rescue and achieve higher quality and quantity of cells without introducing bias, high pressure, and modifications to gene expression profiles, ensuring the integrity of downstream data and analysis is maintained.
Meet the team behind the #levitationrevolution.
Leadership Team

Martin Pieprzyk, MS/MBA
Chief Executive Officer

Dominique Remy-Renou
SVP of Global Commercial Operations

Gang Sun, Ph.D
SVP of Software & Bioinformatics

Geoff Facer, Ph.D
VP of Engineering

Steven Collier, Ph.D
General Counsel

Mike Lee, MS
VP of Operations

Kevin Travers, Ph.D
VP of R&D

Joe Walthers, CPA
VP of Finance
Scientific Founding Team

Gozde Durmus, Ph.D

Utkan Demirci, Ph.D

Lars Steinmetz, Ph.D
Board Members

Greg Herrema, MBA
Advisor

Phillips Huang, Ph.D
Observer

Paul Meister
Observer

Martin Pieprzyk, MS/MBA
Chief Executive Officer

Steve Tablak
Independent Board Member

Victor Tong
Partner